# Why predictive intelligence is changing the Medical Science Liaison model

- Link: https://www.directorstalkinterviews.com/why-predictive-intelligence-is-changing-the-medical-science-liaison-model/4121243913
- Published: 2026-03-10T10:31:00+00:00
- Author: Amilia Stone

Medical Science Liaisons have traditionally been the scientific connection between
pharmaceutical companies and healthcare professionals. Their role is centred on 
non promotional dialogue, explaining clinical evidence, answering scientific questions
and collecting feedback from the field. For many years this model relied on structured
engagement plans, established opinion leaders and scheduled interactions at congresses
or advisory boards.

However, the information environment surrounding modern healthcare has changed significantly.
Scientific debate now develops continuously across digital platforms, academic publications
and professional networks. Clinicians discuss emerging evidence faster and across
more channels than before.

The challenge for Medical Affairs teams is not simply operational. Pharmaceutical
companies increasingly rely on Medical Affairs to provide early visibility on shifts
in clinical thinking, treatment behaviour and emerging scientific questions. If 
insight from the field arrives too slowly, the organisation may miss early signals
that influence how therapies are positioned, studied or adopted in practice.

Traditional MSL planning typically focuses on a fixed group of recognised experts.
While these relationships remain valuable, influence in healthcare conversations
is now more fluid. New voices often emerge quickly around specific research topics,
clinical questions or therapeutic developments. Identifying these individuals early
can be important for companies seeking to understand how medical narratives are 
evolving.

Predictive intelligence offers a way to address this gap. By analysing large volumes
of healthcare discussion, scientific publication activity and other behavioural 
signals, data models can identify patterns that indicate where medical conversations
are forming and who is shaping them. This allows Medical Affairs teams to prioritise
engagement based on current influence rather than relying solely on historical relationships.

_**[Tern plc](https://www.directorstalkinterviews.com/company/tern-plc/tern.l) **(
[LON:TERN](https://www.directorstalkinterviews.com/company/tern-plc/tern.l)) backs
exciting, high growth IoT innovators in Europe. They provide support and create 
a genuinely collaborative environment for talented, well-motivated teams. _

Share on:
